-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Wanbond (002082.SZ) issued an announcement. The phase I clinical trial of the new drug WP107 to treat myasthenia gravis, a wholly-owned subsidiary of the company, obtained review approval from the Medical Ethics Committee of Yuying Children's Hospital Affiliated to Wenzhou Medical University of the Second Affiliated Hospital of Wenzhou Medical University and approved the launch of the project.

Zhitongcaijing·12/29/2025 09:17:10
Listen to the news
Zhitong Finance App News, Wanbond (002082.SZ) issued an announcement. The phase I clinical trial of the new drug WP107 to treat myasthenia gravis, a wholly-owned subsidiary of the company, obtained review approval from the Medical Ethics Committee of Yuying Children's Hospital Affiliated to Wenzhou Medical University of the Second Affiliated Hospital of Wenzhou Medical University and approved the launch of the project.